Nanfang-Chunfu Children’s Institute of Hematology & Oncology

The Nanfang-Chunfu Children’s Institute of Hematology & Oncology

The Nanfang-Chunfu Children’s Institute of Hematology & Oncology, referred to as the GoBroad Healthcare (Hematology) Guangdong Research Center, is a medical establishment directed by Professor Chunfu Li. It specializes in hematology research, diagnosis, and treatment; collaborates strategically with the Mayo Clinic; and amalgamates medical care, education, and scientific inquiry.

The facility employs a comprehensive diagnostic system alongside advanced chemical and biomedical technologies to establish systematic diagnosis and treatment protocols for hematological and immune disorders. With 150 standard wards and 36 designated transplant rooms, it has evolved into a prominent global center for pediatric hematopoietic stem cell transplantation (HSCT).

Between July 2018 and November 2023, 1186 patients underwent HSCT at this center. The conditions encompassed hematologic and immune system disorders: thalassemia, juvenile myelomonocytic leukemia (JMML), acute myeloid leukemia (AML), acute lymphoblastic leukemia (ALL), aplastic anemia (AA), systemic lupus erythematosus (SLE), immunodeficiency disorders, among others. The technology of haploidentical transplantation, including Tαβ+ Cell Depleted HSCT (TDH), has been effectively established, comprising 69.89% of the total transplants.

The Nanfang-Chunfu Children’s Institute of Hematology & Oncology was prominently featured through numerous selected oral presentations and posters at both the ASH Annual Meeting and Exposition and the Annual Congress of the European Hematology Association (EHA). Numerous clinical research findings were disseminated in Blood, Leukemia, and other prestigious academic journals. The pioneering Complementary Transplantation Protocol for thalassemia patients has attained an overall survival (OS) rate of 97.6%, the highest outcome for thalassemia transplantation globally.

• Pediatric hematoloty
• Pediatric oncology
• Hematopoietic stem cell transplantation
• Thalassemia
• Pediatric Acute Myeloid Leukemia
• Pediatric lymphoma

The Nanfang-Chunfu Children’s Institute of Hematology & Oncology, located within Taixin Hospital in Dongguan, China, is a prominent center specializing in pediatric hematology and oncology.

The institute offers advanced treatments for various childhood cancers and blood disorders, including hematopoietic stem cell transplantation (HSCT). Notably, Nanfang Hospital, associated with the institute, has achieved excellent outcomes using novel HSCT regimens.

Besides HSCT, the institute is also involved in clinical trials for chimeric antigen receptor T-cell (CAR-T) therapy, focusing on hard-to-treat leukemia and neuroblastoma, showing its dedication to advanced treatments.

The institute’s multidisciplinary team collaborates closely with other leading centers to enhance pediatric cancer care in China.

The Nanfang-Chunfu Children’s Institute of Hematology & Oncology, situated within Taixin Hospital in Dongguan, China, is a specialized center dedicated to diagnosing and treating pediatric hematological diseases and cancers. The institute’s infrastructure is designed to provide comprehensive care, encompassing advanced diagnostic and therapeutic facilities.

Specialized Facilities:

• Diagnostic Laboratories: The institute is equipped with state-of-the-art laboratories capable of conducting detailed analyses for various hematological conditions, including thalassemia, aplastic anemia, and congenital bone marrow failures.
• Stem Cell Transplantation Units: Recognized for its expertise in hematopoietic stem cell transplantation (HSCT), the institute offers specialized units designed to support both autologous and allogeneic transplants, adhering to stringent safety and quality standards.
• CAR-T Cell Therapy Facilities: The institute is actively engaged in clinical trials for chimeric antigen receptor T-cell (CAR-T) therapy, targeting refractory leukemia and neuroblastoma, reflecting its commitment to cutting-edge treatments.

Pic: Patient admission room

Supportive Care Services:

• Multidisciplinary Care Teams: A collaborative approach involving pediatric oncologists, hematologists, nurses, and support staff ensures holistic care tailored to each patient’s needs.
• Patient and Family Support: Comprehensive support services, including counseling and educational programs, are available to assist patients and their families throughout the treatment journey.

Through its specialized infrastructure and dedicated services, the Nanfang-Chunfu Children’s Institute of Hematology & Oncology strives to provide exceptional care for children facing hematological and oncological challenges.

Pic: Nanfang-Chunfu Children’s Institute of Hematology & Oncology front view

The Nanfang-Chunfu Children’s Institute of Hematology & Oncology is situated at No. 2, Taixin, Lixin Management District, Dongcheng District, Dongguan City, Guangdong Province, China, with the postal code 523128. Dongguan City is a significant industrial and commercial hub in Guangdong Province, located in the southern part of China. The institute’s location within the Dongcheng District provides accessibility for both local and international patients seeking specialized pediatric hematology and oncology care.

Nanfang-Chunfu Children’s Institute of Hematology & Oncology

Address: No. 2, Taixin, Lixin Management District,

Dongcheng District,

Dongguan City,

Guangdong Province

Zip code: 523128

The Nanfang-Chunfu Children’s Institute of Hematology & Oncology, also known as GoBroad Healthcare (Hematology) Guangdong Research Center, was established in 2018 and is dedicated to the diagnosis and treatment of pediatric hematological diseases and cancers.

Key Facilities:

• Patient Wards: The institute houses 150 standard wards and 36 specialized transplant rooms, positioning it as a leading global center for pediatric hematopoietic stem cell transplantation (HSCT).
• Diagnostic Systems: Equipped with comprehensive diagnostic systems and advanced chemical and biomedical technologies, the institute establishes systematic protocols for diagnosing and treating hematological and immune disorders.
• Research and Development: The institute is actively involved in research, with its medical team presenting 14 research findings at international academic conferences, reflecting its commitment to addressing unmet patient needs and advancing medical knowledge.

Through its comprehensive facilities and dedicated services, the Nanfang-Chunfu Children’s Institute of Hematology & Oncology strives to provide exceptional care for children facing hematological and oncological challenges.